Droxia (hydroxyurea)

Manufacturer:

Waylis Therapeutics

Route of Administration:

Oral

Site of Care:

Outpatient

Website:

Manufacturer Website

phone:

Enrollment Forms:

Synergen Prescription Form

Patient Support Form

Approved Indication:

reducing the frequency of painful crises and the need for blood transfusions in patients with sickle cell anemia with recurrent moderate to severe painful crises

Conditions:

Sickle Cell Disease